Skip to main content
Signal8

BROADWOOD PARTNERS, L.P.

SEC insider (Form 3/4/5 filer). CIK 0001278386. 10% Owner at Insight Molecular Diagnostics Inc. (IMDX) and 2 other issuers. 120 reported Form 4/5 transactions since Sep 2024; latest on Apr 27, 2026. Located in NEW YORK, NY.

Companies BROADWOOD PARTNERS, L.P. has filed insider reports for

  • Insight Molecular Diagnostics Inc. (IMDX): 10% Owner
  • STAAR SURGICAL CO (STAA): Director, 10% Owner
  • Lineage Cell Therapeutics, Inc. (LCTX): Director, 10% Owner
BROADWOOD PARTNERS, L.P. profile photo

BROADWOOD PARTNERS, L.P.

CIK: 0001278386

Transaction Breakdown

Open Market Buys (P)120 (100.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Insight Molecular Diagnostics Inc. logo
IMDX

Insight Molecular Diagnostics Inc.

10% Owner
STAAR SURGICAL CO logo
STAA

STAAR SURGICAL CO

Director10% Owner
Lineage Cell Therapeutics, Inc. logo
LCTX

Lineage Cell Therapeutics, Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (120 total)

  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Apr 27, 2026
    Purchase
    Indirect
    0 shares-
  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Apr 27, 2026
    Purchase
    Direct
    250.9K shares at avg. $3.64$913K
  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Apr 24, 2026
    Purchase
    Indirect
    0 shares-
  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Apr 24, 2026
    Purchase
    Direct
    38.9K shares at avg. $3.53$137K
  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Apr 23, 2026
    Purchase
    Direct
    280.4K shares at avg. $3.50$982K
  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Apr 23, 2026
    Purchase
    Indirect
    0 shares-
  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Apr 20, 2026
    Purchase
    Direct
    40.7K shares at avg. $3.88$158K
  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Apr 20, 2026
    Purchase
    Indirect
    0 shares-
  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Apr 17, 2026
    Purchase
    Indirect
    0 shares-
  • Insight Molecular Diagnostics Inc. logo
    IMDX

    Insight Molecular Diagnostics Inc.

    Apr 17, 2026
    Purchase
    Direct
    40.1K shares at avg. $3.57$143K

1-10 of 120

…